Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis GA Block, KJ Martin, ALM De Francisco, SA Turner, MM Avram, ... New England Journal of Medicine 350 (15), 1516-1525, 2004 | 1430 | 2004 |
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ... Kidney international 92 (1), 26-36, 2017 | 1061 | 2017 |
Uremic toxins originating from colonic microbial metabolism P Evenepoel, BKI Meijers, BRM Bammens, K Verbeke Kidney International 76, S12-S19, 2009 | 478 | 2009 |
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B Bammens, P Evenepoel, H Keuleers, K Verbeke, Y Vanrenterghem Kidney international 69 (6), 1081-1087, 2006 | 426 | 2006 |
Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study P Evenepoel, K Claes, D Kuypers, B Maes, B Bammens, ... Nephrology Dialysis Transplantation 19 (5), 1281-1287, 2004 | 403 | 2004 |
Role of the gut microbiome in uremia: a potential therapeutic target A Ramezani, ZA Massy, B Meijers, P Evenepoel, R Vanholder, DS Raj American Journal of Kidney Diseases 67 (3), 483-498, 2016 | 386 | 2016 |
Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study BD Maes, R Oyen, K Claes, P Evenepoel, D Kuypers, J Vanwalleghem, ... Kidney international 65 (5), 1842-1849, 2004 | 371 | 2004 |
Diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder: Synopsis of the kidney disease: improving global outcomes 2017 clinical … M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ... Annals of internal medicine 168 (6), 422-430, 2018 | 360 | 2018 |
p-Cresol and cardiovascular risk in mild-to-moderate kidney disease BKI Meijers, K Claes, B Bammens, H de Loor, L Viaene, K Verbeke, ... Clinical journal of the american society of nephrology 5 (7), 1182-1189, 2010 | 347 | 2010 |
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver … W Laleman, A Wilmer, P Evenepoel, IV Elst, M Zeegers, Z Zaman, ... Critical Care 10, 1-13, 2006 | 346 | 2006 |
p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin BKI Meijers, V De Preter, K Verbeke, Y Vanrenterghem, P Evenepoel Nephrology Dialysis Transplantation 25 (1), 219-224, 2010 | 340 | 2010 |
Free p-cresol is associated with cardiovascular disease in hemodialysis patients BKI Meijers, B Bammens, B De Moor, K Verbeke, Y Vanrenterghem, ... Kidney international 73 (10), 1174-1180, 2008 | 338 | 2008 |
The gut–kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression BKI Meijers, P Evenepoel Nephrology Dialysis Transplantation 26 (3), 759-761, 2011 | 323 | 2011 |
Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. B Geypens, D Claus, P Evenepoel, M Hiele, B Maes, M Peeters, ... Gut 41 (1), 70-76, 1997 | 270 | 1997 |
The gut–kidney axis P Evenepoel, R Poesen, B Meijers Pediatric Nephrology 32, 2005-2014, 2017 | 262 | 2017 |
The uremic retention solute p-cresyl sulfate and markers of endothelial damage BKI Meijers, K Verbeke, W Dehaen, Y Vanrenterghem, MF Hoylaerts, ... American Journal of Kidney Diseases 54 (5), 891-901, 2009 | 261 | 2009 |
Intrarenal resistive index after renal transplantation M Naesens, L Heylen, E Lerut, K Claes, L De Wever, F Claus, R Oyen, ... New England Journal of Medicine 369 (19), 1797-1806, 2013 | 239 | 2013 |
Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms B Bammens, P Evenepoel, K Verbeke, Y Vanrenterghem Kidney international 64 (6), 2238-2243, 2003 | 239 | 2003 |
Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study B Bammens, P Evenepoel, K Verbeke, Y Vanrenterghem American journal of kidney diseases 44 (2), 278-285, 2004 | 219 | 2004 |
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long‐term pharmacokinetics in de novo renal allograft recipients DRJ Kuypers, K Claes, P Evenepoel, B Maes, Y Vanrenterghem Clinical Pharmacology & Therapeutics 75 (5), 434-447, 2004 | 217 | 2004 |